HomeFinancial MarketsJohnson & Johnson Raises Its 2023 Profit Forecast After Strong Q2

Johnson & Johnson Raises Its 2023 Profit Forecast After Strong Q2

Pharma giant Johnson & Johnson is expecting to have a better 2023 performance after reporting strong second-quarter earnings on Wednesday. The company benefited from a well-performing medical devices business that saw significant sales growth in the first part of the year. It also benefited from the increased demand for its cancer medication Darzalex and over-the-counter drugs. 

Johnson & Johnson beat the Wall Street estimates in Q2, seeing $2.80 in adjusted earnings per share compared to the $2.62 EPS expected by the analysts. Its revenue came at $25.53 billion versus an estimated $24.62 billion, with a net income of $5.14 billion.

The company now expects to reach between $98.80 billion and $99.80 billion in sales, which represents a $1 billion increase compared to the previous estimate after Q1.

It also raised its earnings prediction to $10.70 to $10.80 per share compared to the $10.60 to $10.70 per share forecast in April. The analysts expected the company to have profits of $10.65 per share for the year.

Johnson & Johnson stock saw a slight movement in pre-market trading on Thursday, at one point reaching $159.30 per share compared to Wednesday’s close of $158.65. The company’s shares have been down almost 11% year-to-date.

Home Sales Plummeted in August According to Pending Data

Pending home sales for August were down 7.1% from the previous month, data from the National Association of Realtors revealed. This far outpaces the...

Stocks Fall After the Release of GDP Data

U.S. stocks declined on Thursday as investors digested the latest round of GDP data. Estimates on Thursday showed that the U.S. economy's GDP for...

Hyundai and Kia Recall Over 3 Million Vehicles Due to Fire Risk

Hyundai and Kia are in the process of recalling over 3.4 million vehicles in the United States due to a fire risk. Both automakers...